General Updates

05th November 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited., National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM) Dear Sir, Sub.: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 In reference to the captioned subject, this is to inform you that an Orders dated 03rd November, 2026 & 04th November, 2026 was passed by Commercial Tax Officer of State Tax, Tiruvallur, Tamil Nadu as per the details provided below: Sr. Particulars Details 1. Name of the authority Commercial Tax Officer of State Tax, Tiruvallur, Tamil Nadu 2. Nature and details of the action Order passed under Section 74 of the Goods and taken, initiated or order passed Service Act, 2017, imposing penalty (aggregated for 4 years) of ₹ 3,12,32,860/- 3. Date of receipt of direction or order, 04th November, 2026 at 06:10 pm including any ad-interim or interim orders, or any other communication from the authority 4. Details of the violation/ The demand pertains to GST matters relating to JB contravention committed or alleged Chemicals and Pharmaceuticals Limited (“JB to be committed Chemicals”) for FY 2020-21 to FY 2023-24 i.e. period prior to its acquisition. 5. Impact on financial, operation, or Based on the Company assessment, an appeal will be other activities of the listed entity, filed and the Company is hopeful of favorable quantifiable in monetary terms to outcome at the appellate level and does not the extent possible reasonably expect the said Order to have any material financial impact on the Company. Kindly take note of the above. Thanking you, Yours sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY